238 related articles for article (PubMed ID: 9195288)
1. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y; Teicher BA
Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
[TBL] [Abstract][Full Text] [Related]
3. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma.
Teicher BA; Holden SA; Ara G; Korbut T; Menon K
Cancer Chemother Pharmacol; 1996; 38(2):169-77. PubMed ID: 8616908
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
Teicher BA; Dupuis NP; Robinson MF; Emi Y; Goff DA
Oncol Res; 1995; 7(5):237-43. PubMed ID: 8534929
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.
Teicher BA; Holden SA; Ara G; Sotomayor EA; Huang ZD; Chen YN; Brem H
Int J Cancer; 1994 Jun; 57(6):920-5. PubMed ID: 7515861
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.
Herbst RS; Takeuchi H; Teicher BA
Cancer Chemother Pharmacol; 1998; 41(6):497-504. PubMed ID: 9554595
[TBL] [Abstract][Full Text] [Related]
7. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Kato T; Sato K; Kakinuma H; Matsuda Y
Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
[TBL] [Abstract][Full Text] [Related]
8. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.
Wietrzyk J; Boratynski J; Grynkiewicz G; Ryczynski A; Radzikowski C; Opolski A
Anticancer Res; 2001; 21(6A):3893-6. PubMed ID: 11911265
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells.
Yatsunami J; Aoki S; Fukuno Y; Kikuchi Y; Kawashima M; Hayashi SI
Int J Oncol; 2000 Dec; 17(6):1151-6. PubMed ID: 11078800
[TBL] [Abstract][Full Text] [Related]
11. TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy.
Teicher BA; Emi Y; Kakeji Y; Northey D
Eur J Cancer; 1996 Dec; 32A(14):2461-6. PubMed ID: 9059334
[No Abstract] [Full Text] [Related]
12. Metabolic drug interactions between angiogenic inhibitor, TNP-470 and anticancer agents in primary cultured hepatocytes and microsomes.
Placidi L; Scott EC; Eckoff D; Bynon S; Sommadossi JP
Drug Metab Dispos; 1999 May; 27(5):623-6. PubMed ID: 10220492
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi S; O'Reilly M; Christofori G; Holmgren L; Grosfeld J; Folkman J; Hanahan D
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2002-7. PubMed ID: 8700875
[TBL] [Abstract][Full Text] [Related]
15. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
Teicher BA; Holden SA; Ara G; Dupuis NP; Liu F; Yuan J; Ikebe M; Kakeji Y
Int J Cancer; 1995 May; 61(5):732-7. PubMed ID: 7768649
[TBL] [Abstract][Full Text] [Related]
16. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
17. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Touil YS; Seguin J; Scherman D; Chabot GG
Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
19. [An experimental study of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of Lewis lung carcinoma].
Xia J; Yang B
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):333-5. PubMed ID: 10920909
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
